Last Updated on eMC 08-12-2017 View medicine  | Bristol-Myers Squibb Pharmaceuticals Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Change to section 6 - marketing authorisation holder

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children/adolescents
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store or dispose
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 4 - possible side effects

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect

Reasons for adding or updating:

  • Improved Electronic Presentation
  • Updates to formatting

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects

Reasons for adding or updating:

  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use

Reasons for adding or updating:

  • Change to warnings or special precautions for use

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC